Exploring how AI can go beyond drug discovery and transform various aspects of medicine, including speeding up and personalizing clinical trials, aiding in early diagnosis and treatment selection, and predicting healthcare resource requirements. The chapter raises the critical question of ensuring AI systems benefit clinicians and patients rather than big tech companies.
As the UK hosts the first global AI safety summit, Guardian science editor Ian Sample joins Madeleine Finlay to look on the bright side and consider some of the huge benefits AI could bring to science. Madeleine also hears from Prof Mihaela van der Schaar, an expert in machine learning in medicine, about how she predicts AI will transform patient care. Help support our independent journalism at
theguardian.com/sciencepod